Neutropenia definition

Of the handful of types of white blood cells we have in our bodies, as many as 70 percent are known as neutrophils. For that reason alone we know that they're going to serve an important role, and the role they serve is to help the immune system fight infections.

"Neutropenia," is defined as an abnormally low count of neutrophils in the bloodstream. While the exact amount can sometimes differ from one practice to another, for the purpose of this entry we will take the amount described by the National Comprehensive Cancer Network in its clinical practice guideline in oncology regarding the prevention and treatment of cancer-related infections.

According to those NCCN guidelines, neutropenia is defined as:

  • --or--

This definition is in accord with the current recommendations of the Infectious Diseases Society of America as well.

Febrile Neutropenia

Neutropenia, when accompanied by a fever (known as febrile neutropenia) is considered an oncologic emergency because the patient is susceptible to a host of opportunistic and potentially fatal infections, and they require immediate medical attention.

Sources and further reading

  • Boyiadzis, Michael M. et al. Hematology-Oncology Therapy. 2007. New York: McGraw Hill, Medical Publishing Division.
  • National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections.
  • Mayo Clinic, Neutropenia

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap